J C Benson1, V Nardi2, A A Madhavan3, M C Bois4, L Saba5, L Savastano6, A Lerman4, G Lanzino6. 1. From the Departments of Radiology (J.C.B., A.A.M.) Benson.john3@mayo.edu. 2. Cardiovascular Medicine (V.N.). 3. From the Departments of Radiology (J.C.B., A.A.M.). 4. Laboratory Medicine and Pathology (M.C.B., A.L.). 5. Department of Medical Sciences (L. Saba), University of Cagliari, Cagliari, Italy. 6. Neurosurgery (L. Savastano, G.L.), Mayo Clinic, Rochester, Minnesota.
Abstract
BACKGROUND AND PURPOSE: The CTA "rim sign" has been proposed as an imaging marker of intraplaque hemorrhage in carotid plaques. This study sought to investigate such findings using histopathologic confirmation. MATERIALS AND METHODS: Included patients had CTA neck imaging <1 year before carotid endarterectomy. On imaging, luminal stenosis and the presence of adventitial (<2-mm peripheral) and "bulky" (≥2-mm) calcifications, total plaque thickness, soft-tissue plaque thickness, calcification thickness, and the presence of ulcerations were assessed. The rim sign was defined as the presence of adventitial calcifications with internal soft-tissue plaque of ≥2 mm in maximum thickness. Carotid endarterectomy specimens were assessed for both the presence and the proportional makeup of lipid material, intraplaque hemorrhage, and calcification. RESULTS: Sixty-seven patients were included. Twenty-three (34.3%) were women; the average age was 70.4 years. Thirty-eight (57.7%) plaques had a rim sign on imaging, with strong interobserver agreement (κ = 0.85). A lipid core was present in 64 (95.5%) plaques (average, 22.2% proportion of plaque composition); intraplaque hemorrhage was present in 52 (77.6%), making up, on average, 13.7% of the plaque composition. The rim sign was not associated with the presence of intraplaque hemorrhage (P = .11); however, it was associated with a greater proportion of intraplaque hemorrhage in a plaque (P = .049). The sensitivity and specificity of the rim sign for intraplaque hemorrhage were 61.5% and 60.0%, respectively. CONCLUSIONS: The rim sign is not associated with the presence of intraplaque hemorrhage on histology. However, it is associated with a higher proportion of hemorrhage within a plaque and therefore may be a biomarker of more severe intraplaque hemorrhage, if present.
BACKGROUND AND PURPOSE: The CTA "rim sign" has been proposed as an imaging marker of intraplaque hemorrhage in carotid plaques. This study sought to investigate such findings using histopathologic confirmation. MATERIALS AND METHODS: Included patients had CTA neck imaging <1 year before carotid endarterectomy. On imaging, luminal stenosis and the presence of adventitial (<2-mm peripheral) and "bulky" (≥2-mm) calcifications, total plaque thickness, soft-tissue plaque thickness, calcification thickness, and the presence of ulcerations were assessed. The rim sign was defined as the presence of adventitial calcifications with internal soft-tissue plaque of ≥2 mm in maximum thickness. Carotid endarterectomy specimens were assessed for both the presence and the proportional makeup of lipid material, intraplaque hemorrhage, and calcification. RESULTS: Sixty-seven patients were included. Twenty-three (34.3%) were women; the average age was 70.4 years. Thirty-eight (57.7%) plaques had a rim sign on imaging, with strong interobserver agreement (κ = 0.85). A lipid core was present in 64 (95.5%) plaques (average, 22.2% proportion of plaque composition); intraplaque hemorrhage was present in 52 (77.6%), making up, on average, 13.7% of the plaque composition. The rim sign was not associated with the presence of intraplaque hemorrhage (P = .11); however, it was associated with a greater proportion of intraplaque hemorrhage in a plaque (P = .049). The sensitivity and specificity of the rim sign for intraplaque hemorrhage were 61.5% and 60.0%, respectively. CONCLUSIONS: The rim sign is not associated with the presence of intraplaque hemorrhage on histology. However, it is associated with a higher proportion of hemorrhage within a plaque and therefore may be a biomarker of more severe intraplaque hemorrhage, if present.
Authors: Jean Marie U-King-Im; Allan J Fox; Richard I Aviv; Peter Howard; Robert Yeung; Alan R Moody; Sean P Symons Journal: Stroke Date: 2010-06-24 Impact factor: 7.914
Authors: M Trelles; K M Eberhardt; M Buchholz; A Schindler; A Bayer-Karpinska; M Dichgans; M F Reiser; K Nikolaou; T Saam Journal: AJNR Am J Neuroradiol Date: 2013-07-18 Impact factor: 3.825
Authors: L B Eisenmenger; B W Aldred; S-E Kim; G J Stoddard; A de Havenon; G S Treiman; D L Parker; J S McNally Journal: AJNR Am J Neuroradiol Date: 2016-04-21 Impact factor: 3.825
Authors: John C Benson; Giuseppe Lanzino; Valentina Nardi; Luis Savastano; Amir Lerman; Waleed Brinjikji Journal: Neuroradiology Date: 2021-02-05 Impact factor: 2.804
Authors: L Saba; C Yuan; T S Hatsukami; N Balu; Y Qiao; J K DeMarco; T Saam; A R Moody; D Li; C C Matouk; M H Johnson; H R Jäger; M Mossa-Basha; M E Kooi; Z Fan; D Saloner; M Wintermark; D J Mikulis; B A Wasserman Journal: AJNR Am J Neuroradiol Date: 2018-01-11 Impact factor: 3.825
Authors: John C Benson; Heidi Cheek; Marie C Aubry; Giuseppe Lanzino; John Huston Iii; Alejandro Rabinstein; Waleed Brinjikji Journal: Clin Neuroradiol Date: 2021-01-04 Impact factor: 3.649
Authors: Wael E Shaalan; Hongwei Cheng; Bruce Gewertz; James F McKinsey; Lewis B Schwartz; Daniel Katz; Dindcai Cao; Tina Desai; Seymour Glagov; Hisham S Bassiouny Journal: J Vasc Surg Date: 2004-08 Impact factor: 4.268
Authors: L Saba; W Brinjikji; J D Spence; M Wintermark; M Castillo; G J de Borst; Q Yang; C Yuan; A Buckler; M Edjlali; T Saam; D Saloner; B K Lal; D Capodanno; J Sun; N Balu; R Naylor; A V D Lugt; B A Wasserman; M E Kooi; J Wardlaw; J Gillard; G Lanzino; U Hedin; D Mikulis; A Gupta; J K DeMarco; C Hess; J V Goethem; T Hatsukami; P Rothwell; M M Brown; A R Moody Journal: AJNR Am J Neuroradiol Date: 2021-07-29 Impact factor: 4.966